Expression of H3N2 nucleoprotein in maize seeds and immunogenicity in mice

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Plant Cell Reports

• Publication date

  2015-02-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00299-015-1758-0PMID 25677970
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral immunization of haemaggulutinin H5 expressed in plant endoplasmic reticulum with adjuvant saponin protects mice against highly pathogenic avian influenza A virus infection.

  2015cited by this paper
• Maximal immune response and cross protection by influenza virus nucleoprotein derived from E. coli using an optimized formulation.

  2014cited by this paper
• Medical research: Ebola therapy protects severely ill monkeys

  2014cited by this paper
• Seed-Based Expression Strategies

  2014cited by this paper
• Genetically Engineered Plants as a Source of Vaccines Against Wide Spread Diseases

  2014cited by this paper
• Plant molecular pharming for the treatment of chronic and infectious diseases.

  2014cited by this paper
• Development of universal influenza vaccines based on influenza virus M and NP genes

  2014cited by this paper
• Transgenic rice endosperm as a bioreactor for molecular pharming

  2014cited by this paper
• Intranasal Delivery of Influenza rNP Adjuvanted with c-di-AMP Induces Strong Humoral and Cellular Immune Responses and Provides Protection against Virus Challenge

  2014cited by this paper
• Immunological aspects of using plant cells as delivery vehicles for oral vaccines

  2014cited by this paper
• Tibetan plateau gets wired up for monsoon prediction

  2014cited by this paper
• Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp™

  2014cited by this paper
• The role and assembly mechanism of nucleoprotein in influenza A virus ribonucleoprotein complexes

  2013cited by this paper
• Haemagglutinin and nucleoprotein replicon particle vaccination of swine protects against the pandemic H1N1 2009 virus

  2013cited by this paper
• Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection

  2013cited by this paper
• Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice

  2012influential reference
• Molecular Farming in Plants: Recent Advances and Future Prospects

  2012cited by this paper
• Production of highly concentrated, heat-stable hepatitis B surface antigen in maize.

  2012cited by this paper
• Mucosal immunity and nasal influenza vaccination

  2012cited by this paper
• The Production of Vaccines and Therapeutic Antibodies in Plants

  2012cited by this paper
• Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein

  2012cited by this paper
• Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine.

  2011cited by this paper
• Regulation of Antinucleoprotein IgG by Systemic Vaccination and Its Effect on Influenza Virus Clearance

  2011cited by this paper
• Contributions of Antinucleoprotein IgG to Heterosubtypic Immunity against Influenza Virus

  2011cited by this paper
• Influenza A viruses: new research developments

  2011cited by this paper
• Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain

  2010cited by this paper
• Quality control in the endoplasmic reticulum.

  2010cited by this paper
• Influenza vaccines for the future.

  2010cited by this paper
• Plant‐made vaccines for humans and animals

  2010cited by this paper
• A universal influenza A vaccine based on adenovirus expressing matrix-2 ectodomain and nucleoprotein protects mice from lethal challenge.

  2010cited by this paper
• Research and development of universal influenza vaccines.

  2010cited by this paper
• Detection of Anti-Influenza A Nucleoprotein Antibodies in Pigs Using a Commercial Influenza Epitope-Blocking Enzyme-Linked Immunosorbent Assay Developed for Avian Species

  2010cited by this paper
• Genome packaging in influenza A virus.

  2010cited by this paper
• Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus

  2009cited by this paper
• Influenza vaccines for the future

  2009cited by this paper
• Prediction of Glycosylation Sites in Proteins

  2009cited by this paper
• Plant-made vaccine antigens and biopharmaceuticals

  2009cited by this paper
• Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans

  2009cited by this paper
• A Novel Role for Non-Neutralizing Antibodies against Nucleoprotein in Facilitating Resistance to Influenza Virus1

  2008cited by this paper
• Cross-Recognition of Avian H5N1 Influenza Virus by Human Cytotoxic T-Lymphocyte Populations Directed to Human Influenza A Virus

  2008cited by this paper
• Expression of the rabies virus nucleoprotein in plants at high-levels and evaluation of immune responses in mice

  2008cited by this paper
• Expression of the rabies virus nucleoprotein in plants at high-levels and evaluation of immune responses in mice

  2008cited by this paper
• CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.

  2008cited by this paper
• Enhancement of Innate and Adaptive Immune Functions by Multiple Echinacea Species

  2007cited by this paper
• Oral immunization with transgenic rice seeds expressing VP2 protein of infectious bursal disease virus induces protective immune responses in chickens.

  2007cited by this paper
• Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine.

  2007cited by this paper
• Vaxfectin™-Formulated Influenza DNA Vaccines Encoding NP and M2 Viral Proteins Protect Mice against Lethal Viral Challenge

  2007cited by this paper
• Journal of Experimental Botany, Page 1 of 16

  2006cited by this paper
• Host Species Barriers to Influenza Virus Infections

  2006cited by this paper
• Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.

  2005cited by this paper
• Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

  2005cited by this paper
• Tissue-specific expression in transgenic maize of four endosperm promoters from maize and rice

  2004cited by this paper
• Silencing in Arabidopsis T-DNA Transformants: The Predominant Role of a Gene-Specific RNA Sensing Mechanism versus Position Effects

  2004cited by this paper
• Assessment of conditions affecting Agrobacterium-mediated soybean transformation using the cotyledonary node explant

  2004cited by this paper
• The association of culm anatomy with lodging susceptibility in modern spring wheat genotypes

  2004cited by this paper
• Genetic modification: The production of recombinant pharmaceutical proteins in plants

  2003influential reference
• Quality control in the endoplasmic reticulum

  2003cited by this paper
• Criteria for high-level expression of a fungal laccase gene in transgenic maize.

  2003cited by this paper
• A Functional Antigen in a Practical Crop: LT-B Producing Maize Protects Mice against Escherichia coli Heat Labile Enterotoxin (LT) and Cholera Toxin (CT)

  2002influential reference
• Agrobacterium tumefaciens-Mediated Transformation of Maize Embryos Using a Standard Binary Vector System1

  2002cited by this paper
• DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

  2002cited by this paper
• The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication.

  2002cited by this paper
• Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants

  2001cited by this paper
• IFN-γ-independent IgG2a production in mice infected with viruses and parasites

  2000cited by this paper
• Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase.

  2000cited by this paper
• IFN-gamma-independent IgG2a production in mice infected with viruses and parasites.

  2000cited by this paper
• Transgenic plants as factories for biopharmaceuticals

  2000cited by this paper
• DNA Vaccine Encoding Hemagglutinin Provides Protective Immunity against H5N1 Influenza Virus Infection in Mice

  1999cited by this paper
• Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes.

  1999cited by this paper
• Modulating the immune response to genetic immunization

  1998cited by this paper
• Review Article: The Silence of Genes in Transgenic Plants

  1997cited by this paper
• Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery

  1996cited by this paper
• Inactivation of gene expression in plants as a consequence of specific sequence duplication.

  1994cited by this paper
• Identification of a methyl jasmonate-responsive domain in the soybean vspB promoter.

  1993cited by this paper
• Isolation of plant DNA from fresh tissue

  1990cited by this paper
• A C-terminal signal prevents secretion of luminal ER proteins.

  1987cited by this paper
• Purified influenza virus nucleoprotein protects mice from lethal infection.

  1987cited by this paper
• The hypervirulence of Agrobacterium tumefaciens A281 is encoded in a region of pTiBo542 outside of T-DNA

  1986cited by this paper
• Quantitative analysis of the accumulation of Zein mRNA during maize endosperm development.

  1985cited by this paper
• Cytotoxic T cells recognize fragments of the influenza nucleoprotein.

  1985cited by this paper
• Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes.

  1985cited by this paper
• Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells.

  1984cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Exploring recent progress of molecular farming for therapeutic and recombinant molecules in plant systems

  2024cites this paper
• Recent Progress and Challenges in the Development of Edible Vaccines Produced by Genetically Modified Plants.

  2023cites this paper
• Establishment of the Daucus carota SMC-1 Cell Suspension Line for Poliovirus Vaccine Development

  2023influential citation
• Recent advances in molecular farming using monocot plants.

  2022cites this paper
• Plant-Derived Recombinant Vaccines against Zoonotic Viruses

  2022cites this paper
• Immunogenicity of engineered probiotics expressing conserved antigens of influenza virus and FLIC flagellin against H9N2 AIVinfection in mice.

  2022cites this paper
• Producing Vaccines against Enveloped Viruses in Plants: Making the Impossible, Difficult

  2021cites this paper
• Plant-based expression of SARS-CoV-2 antigen for use in an oral vaccine

  2021cites this paper
• Plant-based vaccine research development against viral diseases with emphasis on Ebola virus disease: A review study.

  2021cites this paper
• Synthesized swine influenza NS1 antigen provides a protective immunity in a mice model

  2020cites this paper
• Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development

  2020cites this paper
• Rapid production in maize seedlings of the Ag85B antigen of Mycobacterium avium subsp. paratuberculosis using an Agrobacterium-mediated transient expression system

  2020cites this paper
• Novel approaches for the design, delivery and administration of vaccine technologies

  2019cites this paper
• Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats

  2019cites this paper
• Engineering Plants for the Future: Farming with Value-Added Harvest

  2018cites this paper
• Design of a Type-1 Diabetes Vaccine Candidate Using Edible Plants Expressing a Major Autoantigen

  2018cites this paper
• Prospects of Plant-Based Vaccines in Veterinary Medicine

  2018cites this paper
• Platforms for Plant-Based Protein Production

  2018cites this paper
• Plant-Produced Avian Influenza Antigens

  2018cites this paper
• Using transgenic plants and modified plant viruses for the development of treatments for human diseases

  2017cites this paper
• High accumulation in tobacco seeds of hemagglutinin antigen from avian (H5N1) influenza

  2017influential citation
• Bioprocessing of Plant In Vitro Systems

  2017influential citation
• Transgenesis and Plant Molecular Pharming

  2017cites this paper
• Corn-based vaccines: current status and prospects

  2017influential citation
• Oral Administration of a Seed-based Bivalent Rotavirus Vaccine Containing VP6 and NSP4 Induces Specific Immune Responses in Mice

  2017cites this paper
• Edible plants for oral delivery of biopharmaceuticals.

  2017cites this paper
• Plant Molecular Pharming

  2016cites this paper
• Plant‐based oral vaccines against zoonotic and non‐zoonotic diseases

  2016cites this paper
• Plant-made oral vaccines against human infectious diseases-Are we there yet?

  2015cites this paper